12:00 AM
 | 
Jan 21, 2013
 |  BC Week In Review  |  Company News  |  Other News

China Nuokang hematology, cardiovascular news

China Nuokang adjourned its Jan. 15 general meeting of shareholders, which it called to authorize and approve the proposal to go private from CEO and Chairman Baizhong Xue. The company decided to adjourn the meeting without conducting any business after Kingbird...

Read the full 184 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >